{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:39:09Z","timestamp":1792723149224,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K15769"],"award-info":[{"award-number":["23K15769"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K08785"],"award-info":[{"award-number":["23K08785"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16533-x","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:56:11Z","timestamp":1785243371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigation of the significance and role of androgen receptor expression in basal\/squamous type urothelial carcinoma cell line J82 cells"],"prefix":"10.1186","volume":"26","author":[{"given":"Ryotaro","family":"Sakai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuko","family":"Hata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"16533_CR1","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","volume":"38","author":"A Richters","year":"2020","unstructured":"Richters A, Aben KKH, Kiemeney LALM. The global burden of urinary bladder cancer: an update. World J Urol. 2020;38:1895\u2013904. https:\/\/doi.org\/10.1007\/s00345-019-02984-4.","journal-title":"World J Urol"},{"key":"16533_CR2","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.eururo.2015.08.037","volume":"69","author":"J Dobruch","year":"2016","unstructured":"Dobruch J, Daneshmand S, Fisch M, Lotan Y, Noon AP, Resnick MJ, Shariat SF, Zlotta AR, Boorjian SA. Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes. Eur Urol. 2016;69:300\u201310. https:\/\/doi.org\/10.1016\/j.eururo.2015.08.037.","journal-title":"Eur Urol"},{"key":"16533_CR3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.urology.2020.05.067","volume":"151","author":"ZG Gul","year":"2021","unstructured":"Gul ZG, Liaw CW, Mehrazin R. Gender differences in incidence, diagnosis, treatments, and outcomes in clinically localized bladder and renal cancer. Urology. 2021;151:176\u201381. https:\/\/doi.org\/10.1016\/j.urology.2020.05.067.","journal-title":"Urology"},{"key":"16533_CR4","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","volume":"77","author":"A Kamoun","year":"2020","unstructured":"Kamoun A, de Reyni\u00e8s A, Allory Y, Sj\u00f6dahl G, Robertson AG, Seiler R, Hoadley KA, Groeneveld CS, Al-Ahmadie H, Choi W, et al. A consensus molecular classification of muscle-invasive bladder cancer. Eur Urol. 2020;77:420\u201333. https:\/\/doi.org\/10.1016\/j.eururo.2019.09.006.","journal-title":"Eur Urol"},{"key":"16533_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature12965","volume":"507","author":"JN Weinstein","year":"2014","unstructured":"Weinstein JN, Akbani R, Broom BM, Wang W, Verhaak RGW, McConkey D, Lerner S, Morgan M, Creighton CJ, Smith C, et al. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014;507:315\u201322. https:\/\/doi.org\/10.1038\/nature12965.","journal-title":"Nature"},{"key":"16533_CR6","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","volume":"25","author":"W Choi","year":"2014","unstructured":"Choi W, Porten S, Kim S, Willis D, Plimack ER, Hoffman-Censits J, Roth B, Cheng T, Tran M, Lee IL, et al. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell. 2014;25:152\u201365. https:\/\/doi.org\/10.1016\/j.ccr.2014.01.009.","journal-title":"Cancer Cell"},{"key":"16533_CR7","doi-asserted-by":"publisher","first-page":"643870","DOI":"10.3389\/fendo.2021.643870","volume":"12","author":"T Goto","year":"2021","unstructured":"Goto T, Miyamoto H. The role of estrogen receptors in urothelial cancer. Front Endocrinol (Lausanne). 2021;12:643870. https:\/\/doi.org\/10.3389\/fendo.2021.643870.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"16533_CR8","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3390\/cells10051169","volume":"10","author":"H Ide","year":"2021","unstructured":"Ide H, Miyamoto H. Sex hormone receptor signaling in bladder cancer: a potential target for enhancing the efficacy of conventional non-surgical therapy. Cells. 2021;10:1169. https:\/\/doi.org\/10.3390\/cells10051169.","journal-title":"Cells"},{"key":"16533_CR9","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1038\/s41388-020-1153-3","volume":"39","author":"JK Lempi\u00e4inen","year":"2020","unstructured":"Lempi\u00e4inen JK, Manjur ABMK, Malinen M, Ketola K, Niskanen EA, Palvimo JJ. BCOR-coupled H2A monoubiquitination represses a subset of androgen receptor target genes regulating prostate cancer proliferation. Oncogene. 2020;39:2391\u2013407. https:\/\/doi.org\/10.1038\/s41388-020-1153-3.","journal-title":"Oncogene"},{"key":"16533_CR10","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1101\/gad.1965810","volume":"24","author":"MM Shen","year":"2010","unstructured":"Shen MM, Abate-Shen C. Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev. 2010;24:1967\u20132000. https:\/\/doi.org\/10.1101\/gad.1965810.","journal-title":"Genes Dev"},{"key":"16533_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1146\/annurev-physiol-030212-183656","volume":"75","author":"T Matsumoto","year":"2013","unstructured":"Matsumoto T, Sakari M, Okada M, Yokoyama A, Takahashi S, Kouzmenko A, Kato S. The androgen receptor in health and disease. Annu Rev Physiol. 2013;75:201\u201324. https:\/\/doi.org\/10.1146\/annurev-physiol-030212-183656.","journal-title":"Annu Rev Physiol"},{"key":"16533_CR12","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrc4016","volume":"15","author":"PA Watson","year":"2015","unstructured":"Watson PA, Arora VK, Sawyers CL. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer. Nat Rev Cancer. 2015;15:701\u201311. https:\/\/doi.org\/10.1038\/nrc4016.","journal-title":"Nat Rev Cancer"},{"key":"16533_CR13","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","volume":"83","author":"DJ Mangelsdorf","year":"1995","unstructured":"Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Sch\u00fctz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, et al. The nuclear receptor superfamily: the second decade. Cell. 1995;83:835\u20139. https:\/\/doi.org\/10.1016\/0092-8674(95)90199-X.","journal-title":"Cell"},{"key":"16533_CR14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1126\/science.3353727","volume":"240","author":"DB Lubahn","year":"1988","unstructured":"Lubahn DB, Joseph DR, Sullivan PM, Willard HF, French FS, Wilson EM. Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science. 1988;240:327\u201330. https:\/\/doi.org\/10.1126\/science.3353727.","journal-title":"Science"},{"key":"16533_CR15","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ajur.2020.05.011","volume":"7","author":"A Tripathi","year":"2020","unstructured":"Tripathi A, Gupta S. Androgen receptor in bladder cancer: a promising therapeutic target. Asian J Urol. 2020;7:284\u201390. https:\/\/doi.org\/10.1016\/j.ajur.2020.05.011.","journal-title":"Asian J Urol"},{"key":"16533_CR16","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41585-023-00761-y","volume":"20","author":"J Chen","year":"2023","unstructured":"Chen J, Huang CP, Quan C, Zu X, Ou Z, Tsai YC, Messing E, Yeh S, Chang C. The androgen receptor in bladder cancer. Nat Rev Urol. 2023;20:560\u201374. https:\/\/doi.org\/10.1038\/s41585-023-00761-y.","journal-title":"Nat Rev Urol"},{"key":"16533_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.lfs.2017.09.029","volume":"190","author":"S Hata","year":"2017","unstructured":"Hata S, Ise K, Azmahani A, Konosu-Fukaya S, McNamara KM, Fujishima F, Shimada K, Mitsuzuka K, Arai Y, Sasano H, et al. Expression of AR, 5\u03b1R1 and 5\u03b1R2 in bladder urothelial carcinoma and relationship to clinicopathological factors. Life Sci. 2017;190:15\u201320. https:\/\/doi.org\/10.1016\/j.lfs.2017.09.029.","journal-title":"Life Sci"},{"key":"16533_CR18","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3906\/biy-2107-72","volume":"45","author":"A Eray","year":"2021","unstructured":"Eray A, Erkek-\u00d6zhan S. Classification of bladder cancer cell lines according to regulon activity. Turk J Biol. 2021;45:656\u201368. https:\/\/doi.org\/10.3906\/biy-2107-72.","journal-title":"Turk J Biol"},{"key":"16533_CR19","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1002\/1878-0261.12957","volume":"15","author":"MV Luna-Velez","year":"2021","unstructured":"Luna-Velez MV, Dijkstra JJ, Heuschkel MA, Smit FP, van de Zande G, Smeets D, Sedelaar JPM, Vermeulen M, Verhaegh GW, Schalken JA. Androgen receptor signalling confers clonogenic and migratory advantages in urothelial cell carcinoma of the bladder. Mol Oncol. 2021;15:1882\u2013900. https:\/\/doi.org\/10.1002\/1878-0261.12957.","journal-title":"Mol Oncol"},{"key":"16533_CR20","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1210\/mend.13.3.0254","volume":"13","author":"S Lu","year":"1999","unstructured":"Lu S, Liu M, Epner DE, Tsai SY, Tsai MJ. Androgen regulation of the cyclin-dependent kinase inhibitor p21 gene through an androgen response element in the proximal promoter. Mol Endocrinol. 1999;13:376\u201384. https:\/\/doi.org\/10.1210\/mend.13.3.0254.","journal-title":"Mol Endocrinol"},{"key":"16533_CR21","doi-asserted-by":"publisher","first-page":"5245","DOI":"10.1158\/0008-5472.CAN-04-0496","volume":"64","author":"CL Andersen","year":"2004","unstructured":"Andersen CL, Jensen JL, \u00d8rntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004;64:5245\u201350. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-0496.","journal-title":"Cancer Res"},{"key":"16533_CR22","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1038\/s41598-018-19458-z","volume":"8","author":"VP Souza","year":"2018","unstructured":"Souza VP, Yamamoto MM, Silva GM, et al. Identification of valid reference genes for mRNA and microRNA normalisation in prostate cancer cell lines. Sci Rep. 2018;8:1846. https:\/\/doi.org\/10.1038\/s41598-018-19458-z.","journal-title":"Sci Rep"},{"key":"16533_CR23","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1126\/science.1168175","volume":"324","author":"C Tran","year":"2009","unstructured":"Tran C, Ouk S, Clegg NJ, Chen Y, Watson PA, Arora V, Wongvipat J, Smith-Jones PM, Yoo D, Kwon A, et al. Development of a second-generation antiandrogen for treatment of advanced prostate cancer. Science. 2009;324:787\u201390. https:\/\/doi.org\/10.1126\/science.1168175.","journal-title":"Science"},{"key":"16533_CR24","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nrc2657","volume":"9","author":"T Abbas","year":"2009","unstructured":"Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer. 2009;9:400\u201314. https:\/\/doi.org\/10.1038\/nrc2657.","journal-title":"Nat Rev Cancer"},{"key":"16533_CR25","doi-asserted-by":"publisher","first-page":"541957","DOI":"10.1155\/2010\/541957","volume":"2010","author":"P Dhawan","year":"2010","unstructured":"Dhawan P, Singh AB, Sharma A. Claudin family of proteins and cancer: an overview. J Oncol. 2010;2010:541957. https:\/\/doi.org\/10.1155\/2010\/541957.","journal-title":"J Oncol"},{"key":"16533_CR26","first-page":"3406","volume":"11","author":"J Li","year":"2021","unstructured":"Li J. Targeting claudins in cancer: diagnosis, prognosis and therapy. Am J Cancer Res. 2021;11:3406\u201324.","journal-title":"Am J Cancer Res"},{"key":"16533_CR27","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.cell.2006.09.048","volume":"127","author":"H Kouros-Mehr","year":"2006","unstructured":"Kouros-Mehr H, Slorach EM, Sternlicht MD, Werb Z. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell. 2006;127:1041\u201355. https:\/\/doi.org\/10.1016\/j.cell.2006.09.048.","journal-title":"Cell"},{"key":"16533_CR28","doi-asserted-by":"publisher","first-page":"38531","DOI":"10.1038\/srep38531","volume":"6","author":"JI Warrick","year":"2016","unstructured":"Warrick JI, Walter V, Yamashita H, Chung E, Shuman L, Amponsa VO, Zheng Z, Chan W, Whitcomb TL, Yue F, et al. FOXA1, GATA3 and PPAR\u03b3 cooperate to drive luminal subtype in bladder cancer: a molecular analysis of established human cell lines. Sci Rep. 2016;6:38531. https:\/\/doi.org\/10.1038\/srep38531.","journal-title":"Sci Rep"},{"key":"16533_CR29","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","volume":"179","author":"V Gorgoulis","year":"2019","unstructured":"Gorgoulis V, Adams PD, Alimonti A, Bennett DC, Bischof O, Bishop C, Campisi J, Collado M, Evangelou K, Ferbeyre G, et al. Cellular senescence: defining a path forward. Cell. 2019;179:813\u201327. https:\/\/doi.org\/10.1016\/j.cell.2019.10.005.","journal-title":"Cell"},{"key":"16533_CR30","doi-asserted-by":"publisher","first-page":"100113","DOI":"10.1016\/j.mocell.2024.100113","volume":"47","author":"J Yan","year":"2024","unstructured":"Yan J, Chen S, Yi Z, Zhao R, Zhu J, Ding S, Wu J. The role of p21 in cellular senescence and aging-related diseases. Mol Cells. 2024;47:100113. https:\/\/doi.org\/10.1016\/j.mocell.2024.100113.","journal-title":"Mol Cells"},{"key":"16533_CR31","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1091\/mbc.6.4.387","volume":"6","author":"JW Harper","year":"1995","unstructured":"Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L, Swindell E, et al. Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell. 1995;6:387\u2013400. https:\/\/doi.org\/10.1091\/mbc.6.4.387.","journal-title":"Mol Biol Cell"},{"key":"16533_CR32","doi-asserted-by":"publisher","first-page":"870","DOI":"10.2174\/156800911796798904","volume":"11","author":"M Shiota","year":"2011","unstructured":"Shiota M, Yokomizo A, Fujimoto N, Naito S. Androgen receptor cofactors in prostate cancer: potential therapeutic targets of castration-resistant prostate cancer. Curr Cancer Drug Targets. 2011;11:870\u201381. https:\/\/doi.org\/10.2174\/156800911796798904.","journal-title":"Curr Cancer Drug Targets"},{"key":"16533_CR33","doi-asserted-by":"publisher","first-page":"116338","DOI":"10.1016\/j.biopha.2024.116338","volume":"173","author":"X Li","year":"2024","unstructured":"Li X, Xiong H, Mou X, Huang C, Thomas ER, Yu W, Jiang Y, Chen Y. Androgen receptor cofactors: a potential role in understanding prostate cancer. Biomed Pharmacother. 2024;173:116338. https:\/\/doi.org\/10.1016\/j.biopha.2024.116338.","journal-title":"Biomed Pharmacother"},{"key":"16533_CR34","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1126\/science.1227604","volume":"338","author":"K Xu","year":"2012","unstructured":"Xu K, Wu ZJ, Groner AC, He HH, Cai C, Lis RT, et al. EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent. Science. 2012;338:1465\u20139. https:\/\/doi.org\/10.1126\/science.1227604.","journal-title":"Science"},{"key":"16533_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13045-020-00937-8","volume":"13","author":"R Duan","year":"2020","unstructured":"Duan R, Du W, Guo W. EZH2: a novel target for cancer treatment. J Hematol Oncol. 2020;13:104. https:\/\/doi.org\/10.1186\/s13045-020-00937-8.","journal-title":"J Hematol Oncol"},{"key":"16533_CR36","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s12032-023-02025-6","volume":"40","author":"Y Liu","year":"2023","unstructured":"Liu Y, Yang Q. The roles of EZH2 in cancer and its inhibitors. Med Oncol. 2023;40:167. https:\/\/doi.org\/10.1007\/s12032-023-02025-6.","journal-title":"Med Oncol"},{"key":"16533_CR37","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nm.4036","volume":"22","author":"KH Kim","year":"2016","unstructured":"Kim KH, Roberts CWM. Targeting EZH2 in cancer. Nat Med. 2016;22:128\u201334. https:\/\/doi.org\/10.1038\/nm.4036.","journal-title":"Nat Med"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16533-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16533-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16533-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:06:47Z","timestamp":1792721207000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16533-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16533"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16533-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1283"}}